Radiotherapy in locally advanced & metastatic NSC lung cancer



Similar documents
Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians

Management of spinal cord compression

Radiation Therapy in the Treatment of

Lung Cancer Treatment Guidelines

Radiotherapy in Plasmacytoma and Myeloma. David Cutter Multiple Myeloma NSSG Annual Meeting 14 th September 2015

Management of Non-Small Cell Lung Cancer Guide for General Practitioners

Stage I, II Non Small Cell Lung Cancer

Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD

Case Number: RT (M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor

MALIGNANT SPINAL CORD COMPRESSION. Kate Hamilton Head of Medical Oncology Ballarat Health Services

Small Cell Lung Cancer

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

Table of Contents. Data Supplement 1: Summary of ASTRO Guideline Statements. Data Supplement 2: Definition of Terms

SMALL CELL LUNG CANCER

Corso Integrato di Clinica Medica ONCOLOGIA MEDICA AA LUNG CANCER. VIII. THERAPY. V. SMALL CELL LUNG CANCER Prof.

Multiple Myeloma with Pathologic Fracture: the Role and Treatment Consideration of RT

Acute Oncology Service Patient Information Leaflet

Current Status and Perspectives of Radiation Therapy for Breast Cancer

METASTASES TO THE BONE

Case Number: RT (M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor

Clinical Management Guideline Management of locally advanced or recurrent Renal cell carcinoma. Protocol for Planning and Treatment

Adjuvant Therapy Non Small Cell Lung Cancer. Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015

University College Hospital. Metastatic spinal cord compression (MSCC) information for patients at risk of developing MSCC.

Management of stage III A-B of NSCLC. Hamed ALHusaini Medical Oncologist

A new score predicting the survival of patients with spinal cord compression from myeloma

Medical Oncology. Rotation Goals & Objectives for rotating residents. General Objectives THE UNIVERSITY OF BRITISH COLUMBIA

PRIMARY GLIOMA (oligodendroglioma, astrocytoma, oligodendroglioma, oligoastrocytoma, including anaplastic, gliosarcoma and glioblastoma multiforme)

7. Prostate cancer in PSA relapse

Radiation therapy involves using many terms you may have never heard before. Below is a list of words you could hear during your treatment.

Lung cancer forms in tissues of the lung, usually in the cells lining air passages.

Lung cancer case study

Helical TomoTherapy for Lung Cancer Radiotherapy: Good Science Pays Clinical Dividends Peter Hoban, Ph.D., TomoTherapy Inc.

Alternatives to Surgical Resection for Early Stage Lung Cancer

the standard of care /1/2009 Mesothelioma: The standard of care take home messages PILC 2006 Brussels, March 7, 2009

4.2 Spinal Cord Compression

Radiation Fibrosis Fact Sheet

Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines

RESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What?

Issues Concerning Development of Products for Treatment of Non-Metastatic Castration- Resistant Prostate Cancer (NM-CRPC)

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

Metastatic Breast Cancer: The Art and Science of Systemic Therapy. Vallerie Gordon MD, FRCPC Medical Oncologist CancerCare Manitoba

بسم هللا الرحمن الرحيم

Lung cancer (non-small-cell)

Controversies in Management of. Inoperable NSCLC. Inoperable NSCLC. Introduction:

Radioterapia panencefalica. Umberto Ricardi

a commitment in their practice to the roles and responsibilities of clinical oncologists X

Access to over 53,000 of the world s leading medical experts, from your first day of cover.

Please see the LUCADA data manual v3.1.3, available in the downloads section

CMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014

Radiation Therapy for Non-Small Cell Lung Cancer. Principles of Radiation Therapy for Non-small Cell Lung Cancer

Brain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.

B. Dingle MD, FRCPC, Brian Yaremko MD,FRCPC, R. Ash, MD, FRCPC, P. Truong, MD, FRCPC

POLICY A. INDICATIONS

PATIENT INFORMATION ABOUT ADJUVANT THERAPY AFTER THE WHIPPLE OPERATION FOR ADENOCARCINOMA ( CANCER ) OF THE PANCREAS AND RELATED SITES.

AA Life Insurance providing access to Best Doctors. AA Life Insurance is provided by Friends Life and Pensions Limited

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

AA Life Insurance providing access to Best Doctors. AA Life Insurance is provided by Friends Life Limited

PET/CT in Lung Cancer

Kidney Cancer OVERVIEW

Surgery. Wedge resection only part of the lung, not. not a lobe, is removed. Cancer Council NSW

ROLE OF RADIATION THERAPY FOR RESECTABLE LUNG CANCER

The Brain and Spine CenTer

Stomach (Gastric) Cancer. Prof. M K Mahajan ACDT & RC Bathinda

Principal Investigator: Valerie W. Rusch, MD, FACS, Chief, Thoracic Surgery Memorial Sloan-Kettering Cancer Center

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma

The Di Bella Method (DBM) improves Survival, Objective Response and Performance Status in Breast Cancer

Myeloma pathways to diagnosis UCLP audit

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla

Veterinary Oncology: The Lumps We Hate To Treat

Tricia Cox on 7/18/2012 at Oncology Center. Sarah Randolf. Female

Corso Integrato di Clinica Medica ONCOLOGIA MEDICA AA LUNG CANCER. IV. THERAPY. I. NON SMALL CELL LUNG CANCER Prof.

.org. Metastatic Bone Disease. Description

Current Status and Future Direction of Proton Beam Therapy

REPORT ASCO 1998 LOS ANGELES : LUNG CANCER Johan F. Vansteenkiste, MD, PhD, Univ. Hospital and Leuven Lung Cancer Group

LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis

MALIGNANT LYMPHOMAS. Dr. Olga Vujovic (Updated August 2010)

1400 Telegraph Bloomfield Hills, MI Phone number/ fax Number CANCER TREATMENT

Overview of Gynaecologic Cancer

Radiation Oncology Nursing Care. Helen Lusby Radiation Oncology Nurse BAROC 2012

Level 1. Nutrition & Lifestyle Oncology Certificate

Hospice and Palliative Medicine

Maintenance therapy in in Metastatic NSCLC. Dr Amit Joshi Associate Professor Dept. Of Medical Oncology Tata Memorial Centre Mumbai

Treatment of Small Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians (ACCP) Guideline

Transcription:

Radiotherapy in locally advanced & metastatic NSC lung cancer Dr Raj Hegde. MD. FRANZCR Consultant Radiation Oncologist. William Buckland Radiotherapy Centre. Latrobe Regional Hospital.

Locally advanced lung cancer Results of randomised trail indicate the chemo radiotherapy is the standard care of locally advanced lung cancer. Fatal toxicity uncommon after CT-RT but morbidity can be high in unselected cases. Local control is suboptimal New RT techniques permit improved local control

WBRG/LRH work load. (2013-2014)

WBRG/ LRH

Stage III Lung cancer Treatment of stage III NSCLC remains a very difficult and controversial area mainly because of the large heterogeneity of different pathological conditions that are still included in stage III disease.

Outcomes of stage III NSCLC in 1990. 2D RT Treatment Arms Median survival 5 years survival Standard RT 60Gy/30Fr. 1 Fr/day 11.4 months 5% Hyperfractionated RT 69.9Gy 2 Fr /day 12 months 6% Sequential CT-RT CisPla VBL +60Gy 13.2 months 8%

Concurrent chemo RT Median survival in phase three trials of Chemo RT 22.2 months Albain 2005. 17.79 months Curan 2002, Movsas 2005

Concurrent or sequential RT Concurrent CT-RT reduces the risk of death at 2 years. (RR 0.8:,95 CI 0.78 to 0.95: P=.003) but at the expense of increased toxicity) Choice of optimal CT regime remains unclear. Uncertainties about true magnitude of benefit for concurrent CT RT.

Advances in Radiotherapy planning

Advanced technology. Improved the staging Improved the compliance to treatment Reduced the toxicity Marginal improvement in overall survival

Stage IIIA Groups T1a,b T2a, b T3 N1,2 T4 N0 N1

Early stage and locally advanced (non-metastatic) non-small-cell lung cancer. Treatment Protocols One size does not fit all.

Selection of stage IIIA patients for radical treatment Age ideally <80 Performance status. ECOG 1-2 No severe obstructive airway disease Not more than 10% body weight loss. Ideally less than 5 cm primary tumour Ideally 1-2 mediastinal nodal sites are involved. Less than 5cm distance between primary and nodal metastasis.

Normal tissue tolerance Lung tolerance V20 <30% V30<20% Mean lung dose <15Gy Spinal cord <45 Gy Oesophagus <11 cm Heart V40 < 35Gy

Clinical scenario 1 84 year old male with bad COPD. medically inoperable Ad Ca lung T1N2 disease PET

Stereotactic radiotherapy

.

Bulky Primary disease PET Findings 44 year man with bulky primary disease invading the mediastinum. Ad Ca

T4N2 M0.

Response

Clinical Scenario 3 67 year old fit asymptomatic lady presented with bulky T2N2 MO NSCLC Treatment options Discussed in MDM ( Deemed inoperable) Radical chemo radiotherapy Induction chemo followed by radical RT Palliative Chemo

Surgery Stage III disease

Surgery stage III disease

Yes we can burn that tumour Role of Radiation Oncologist with locally advanced and metastatic lung cancer Yes we can

Treatment plan

Response

Role of induction chemotherapy prior to concurrent treatment Cancer and Leukemia Group B 39801,

Median Survival Cancer and Leukemia Group B 39801, Induction Chemo + CRT 14months (95%CI 11 to16 months) CRT 12 months (95%CI 10 to16 months 2 year survival 31months(95% CI 25 to 38%) 29 months(95% CI 22 to 35%) Toxicity Gr 3 & 4 28 &8% 30& 2%

Role of induction chemotherapy prior to concurrent chemo RT J Clin Oncol. 2007 May 1;25(13):1698-704.

Neo adjuvant

Response after induction Chemo.

Response after induction Chemo

Complications Late Early Radiation Pneumonitis. Radiation fibrosis of the lung, oesophageal stricture. Radiation mylities. Tiredness, Acute exacerbation symptoms, odynophagia

Early Palliative Care for Patients with Metastatic Non Small-Cell Lung Cancer Conclusion Among patients with metastatic nonsmall-cell lung cancer, early palliative care led to significant improvements in both quality of life and mood. As compared with patients receiving standard care, patients receiving early palliative care had less aggressive care at the end of life but longer survival.

Palliative radiotherapy Radiotherapy plays an important role in palliative medicine. Around 20-25% of patients are on palliative treatment at any time in any Radiation Oncology Dept.

Indication Pain relief from bone mets. Prevention of pathological # Spinal cord compression. Impending or actual obstruction hollow viscera. Brain mets. Control of Haemoptysis. Superior Vena caval obstruction.

Spinal cord compression These are common symptoms: Pain and stiffness in the neck, back, or lower back Numbness, cramping, or weakness in the arms, hands, or legs Loss of sensation Difficulty with hand coordination "Foot drop," weakness in a foot that causes a limp Loss of sexual ability Loss of bladder/ bowel control.

Spinal cord compression Poor prognostic factors Complete paraplegia. Loss of Sphincter control. Rapid onset of symptoms ( Infarction).

Immediate action Dexamethasone tablets 8 mag start followed by 4 mg BD. Urgent MRI (If the facilities are available) Immediate referral to a tertiary hospital. Early treatment intervention likely to improve the out come.

Metastatic Spinal cord compression.

Superior Vena Caval Obstruction Management High dose corticosteroids. Radiotherapy to the mediastinum. Superior Venacaval stenting. Chemotherapy (Sensitive tumors like - Lymphomas, Small cell lung cancer, Seminomas, Round cell tumor

Brain Metastasis Management- Solitary Brain Metastasis- (Confirmed after an MRI scan) Good performance status Controlled extra cranial disease Peripheral lesions No significant co. morbid conditions, Surgical excision could be an option

Brain Mets (Multiple ) Treatment Surgical excision of the largest lesion improves neurological deficit and quality of life. Followed by whole brain palliative radiotherapy.

Brain Metastasis- Radiotherapy Palliative whole brain Radiotherapy. Stereotactic Radiotherapy for a solitary or couple of lesions. Radiotherapy to the whole brain following excision of the solitary lesion.

Stereotactic Radiosurgery

Bone Metastasis Pain Hypercalcemia Pathological # Spinal cord compression

Pathological Fracture when > 50% of the cortex is destroyed, the fracture rate increases up to 80%

Pathological # Needs Surgical fixation before Radiotherapy.

At MDM we make Taylor made outfits.

Thank you.